Viyash Scientific Ltd Share Price ₹250

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Viyash Scientific Ltd

Quarter-by-quarter operating performance

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales +	367	333	346	329	361	390	369	774	402	441	850	858	920
Expenses +	370	341	331	307	329	348	330	674	355	389	677	683	736
Operating Profit	-3	-8	15	22	32	42	39	100	46	52	173	176	184
OPM %	-1%	-2%	4%	7%	9%	11%	11%	13%	12%	12%	20%	20%	20%
Other Income +	-60	-23	10	7	-1	3	0	4	1	3	6	-27	16
Interest	11	10	13	13	12	16	14	21	15	14	18	17	15
Depreciation	15	14	15	15	16	16	17	58	16	15	59	59	60
Profit before tax	-89	-56	-3	1	3	12	8	24	16	26	102	73	125
Tax %	4%	-38%	123%	-617%	52%	24%	20%	-71%	36%	31%	29%	34%	47%
Net Profit +	-92	-35	-7	11	1	9	6	42	10	18	73	49	66
EPS in Rs	-3.75	-1.40	-0.34	0.33	-0.04	0.26	0.10	1.78	0.37	0.57	2.18	0.88	1.19

Financials of Viyash Scientific Ltd

Annual income statement trend

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Sales +	443	606	684	848	1,039	1,179	1,362	1,413	1,421	1,370	1,551	3,420
Expenses +	425	550	641	765	914	1,009	1,150	1,303	1,409	1,308	1,390	2,768
Operating Profit	18	56	43	83	125	170	212	109	12	61	162	653
OPM %	4%	9%	6%	10%	12%	14%	16%	8%	1%	4%	10%	19%
Other Income +	48	14	9	436	9	10	-0	11	-58	-6	10	-1
Interest	43	38	28	33	33	36	24	16	36	48	61	69
Depreciation	32	46	40	41	42	51	51	52	56	62	66	234
Profit before tax	-8	-14	-17	444	59	94	137	53	-138	-55	44	349
Tax %	40%	19%	-3%	3%	3%	13%	24%	15%	-11%	-46%	27%	36%
Net Profit +	-12	-16	-16	431	57	82	104	45	-122	-30	32	225
EPS in Rs	-0.70	-0.78	-0.57	17.30	1.97	2.81	3.84	1.65	-4.86	-1.44	0.87	4.06
Dividend Payout %	0%	0%	0%	1%	10%	0%	13%	0%	0%	0%	0%	0%

Financials of Viyash Scientific Ltd

Capital structure and asset base

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	30	48	49	49	49	50	50	50	50	50	50	87
Reserves	61	898	928	599	657	637	678	642	649	607	654	2,824
Borrowings +	473	312	416	305	325	343	277	365	444	488	481	490
Other Liabilities +	343	265	503	380	346	424	381	378	374	389	412	1,228
Total Liabilities	908	1,523	1,896	1,332	1,378	1,454	1,386	1,435	1,517	1,534	1,598	4,628
Fixed Assets +	474	586	684	476	498	577	536	564	605	592	586	2,105
CWIP	39	24	33	18	23	13	31	12	55	16	16	69
Investments	59	428	428	239	180	171	83	38	0	4	0	0
Other Assets +	336	485	751	599	677	693	737	821	856	922	996	2,455
Total Assets	908	1,523	1,896	1,332	1,378	1,454	1,386	1,435	1,517	1,534	1,598	4,628

Financials of Viyash Scientific Ltd

Operating, investing and financing cash movement

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity +	-24	-0	-7	45	116	115	115	31	17	31	83	323
Cash from Investing Activity +	-157	-310	-116	7	-68	-72	10	-94	-65	-6	-25	-84
Cash from Financing Activity +	179	309	147	-57	-20	-43	-139	67	32	-1	-61	-123
Net Cash Flow	-1	-2	24	-5	28	0	-14	4	-16	23	-2	115
Free Cash Flow	-137	-63	-82	0	92	75	70	-1	-58	19	54	225
CFO/OP	-143%	-3%	5%	65%	92%	75%	75%	52%	263%	73%	69%	59%

Financials of Viyash Scientific Ltd

Working capital efficiency and return ratios

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	95	116	136	111	98	99	93	85	88	89	85	112
Inventory Days	153	164	165	125	134	132	139	160	152	166	173	188
Days Payable	147	175	208	127	141	133	119	119	107	121	115	140
Cash Conversion Cycle	101	105	93	110	92	98	112	126	132	135	143	160
Working Capital Days	-111	65	-25	20	33	29	51	54	46	30	70	111
ROCE %	8%	2%	1%	40%	9%	12%	16%	6%	-3%	0%	8%	19%